• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rifampicin activity "in vitro" and in established tuberculosis in mice.

作者信息

Verbist L

出版信息

Acta Tuberc Pneumol Belg. 1969;60(3):397-412.

PMID:4984420
Abstract
摘要

相似文献

1
Rifampicin activity "in vitro" and in established tuberculosis in mice.
Acta Tuberc Pneumol Belg. 1969;60(3):397-412.
2
[Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].[利福平-异烟肼联合用药对小鼠实验性结核病杀菌作用的持久性：可的松试验]
Rev Tuberc Pneumol (Paris). 1970 Mar;34(2):312-9.
3
[Activity of rifampicin on experimental tuberculosis in mice. The development of resistance to rifampicin. Therapeutic effects of combinations of different drugs with rifampicin].
Antibiot Chemother. 1970;16:392-405.
4
Rifampicin.
Ann Ophthalmol. 1971 Aug;3(8):877-82.
5
[Rifampicine in tuberculosis. Peculiarity of its experimental activity and new therapeutic prospects].[利福平在结核病中的应用。其实验活性特点及新的治疗前景]
Pathol Biol (Paris). 1972 Oct;20(19):785-92.
6
Rifampicin: a first line tuberculostatic drug. A critical review and appraisal.利福平：一种一线抗结核药物。批判性综述与评估。
Acta Tuberc Pneumol Belg. 1972 Sep-Dec;63(6):516-28.
7
[Efficacy of rifampicin on experimental mouse tuberculosis].
Jpn J Tuberc Chest Dis. 1970 Jul;16(1):35-43.
8
[Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
Rev Tuberc Pneumol (Paris). 1967 Sep-Oct;31(6):749-62.
9
[On the comparative effectiveness of rifampicin and INI treatment in guinea pigs inoculated with repeated microdoses of bacilli].[利福平与INI治疗反复接种微量杆菌的豚鼠的比较疗效]
Arch Tisiol Mal Appar Respir. 1968 Jun;23(6):435-40.
10
Rifampin--a major new chemotherapeutic agent for the treatment of tuberculosis.利福平——一种治疗结核病的主要新型化疗药物。
N Engl J Med. 1969 Mar 13;280(11):615-6. doi: 10.1056/NEJM196903132801112.

引用本文的文献

1
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.高剂量利福平治疗新涂阳肺结核患者的评估（HIRIF）：一项随机对照试验的研究方案
BMC Infect Dis. 2016 Aug 27;16(1):453. doi: 10.1186/s12879-016-1790-x.
2
Understanding pharmacokinetics to improve tuberculosis treatment outcome.了解药代动力学以改善结核病治疗效果。
Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):813-23. doi: 10.1517/17425255.2014.895813. Epub 2014 Mar 6.
3
Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam.
越南HIV相关结核病患者中利福布汀与洛匹那韦/利托那韦抗逆转录病毒疗法的随机药代动力学试验。
PLoS One. 2014 Jan 22;9(1):e84866. doi: 10.1371/journal.pone.0084866. eCollection 2014.
4
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.利福平与利福喷汀在两种病理特征明显不同的鼠结核病模型中的剂量范围比较。
Antimicrob Agents Chemother. 2012 Aug;56(8):4331-40. doi: 10.1128/AAC.00912-12. Epub 2012 Jun 4.
5
An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.一个预言：抗结核药物代谢动力学-药效学、临床相关性和临床试验模拟预测未来。
Antimicrob Agents Chemother. 2011 Jan;55(1):24-34. doi: 10.1128/AAC.00749-10. Epub 2010 Oct 11.
6
Tuberculosis pharmacotherapy: strategies to optimize patient care.结核病药物治疗：优化患者护理的策略
Expert Opin Pharmacother. 2009 Feb;10(3):381-401. doi: 10.1517/14656560802694564.
7
Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.利福平对结核分枝杆菌的浓度依赖性杀伤作用及耐药性预防
Antimicrob Agents Chemother. 2007 Nov;51(11):3781-8. doi: 10.1128/AAC.01533-06. Epub 2007 Aug 27.
8
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.用于小鼠结核病的强效每周两次含利福喷汀治疗方案。
Am J Respir Crit Care Med. 2006 Jul 1;174(1):94-101. doi: 10.1164/rccm.200602-280OC. Epub 2006 Mar 30.
9
Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong.香港肺结核每日及间歇利福平治疗方案的不良反应
Br Med J. 1972 Mar 25;1(5803):765-71. doi: 10.1136/bmj.1.5803.765.